DaVita Inc. (NYSE:DVA) Given Consensus Recommendation of “Hold” by Analysts

Shares of DaVita Inc. (NYSE:DVA) have been given a consensus rating of “Hold” by the five analysts that are covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and one has issued a buy rating on the company. The average twelve-month price target among analysts that have covered the stock in the last year is $161.80.

A number of research firms have recently weighed in on DVA. Barclays lifted their price target on shares of DaVita from $150.00 to $164.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 31st. Truist Financial raised their price objective on shares of DaVita from $165.00 to $175.00 and gave the stock a “hold” rating in a report on Monday, October 7th.

DaVita Stock Performance

Shares of DVA stock opened at $151.85 on Friday. The company has a debt-to-equity ratio of 15.78, a current ratio of 1.37 and a quick ratio of 1.33. The company’s fifty day moving average price is $157.18 and its two-hundred day moving average price is $150.83. The firm has a market capitalization of $12.45 billion, a P/E ratio of 16.38, a P/E/G ratio of 0.86 and a beta of 0.90. DaVita has a 12 month low of $103.40 and a 12 month high of $169.51.

DaVita (NYSE:DVA) last released its quarterly earnings results on Tuesday, October 29th. The company reported $2.59 EPS for the quarter, missing the consensus estimate of $2.76 by ($0.17). DaVita had a return on equity of 88.18% and a net margin of 6.53%. The business had revenue of $3.26 billion during the quarter, compared to analyst estimates of $3.25 billion. During the same quarter last year, the firm posted $2.85 EPS. The company’s revenue was up 4.6% compared to the same quarter last year. On average, research analysts anticipate that DaVita will post 9.71 earnings per share for the current fiscal year.

Hedge Funds Weigh In On DaVita

A number of hedge funds have recently added to or reduced their stakes in the business. Franklin Resources Inc. lifted its holdings in DaVita by 134.6% in the third quarter. Franklin Resources Inc. now owns 54,901 shares of the company’s stock worth $8,885,000 after acquiring an additional 31,502 shares during the last quarter. Tidal Investments LLC raised its position in shares of DaVita by 45.2% during the 3rd quarter. Tidal Investments LLC now owns 5,688 shares of the company’s stock worth $932,000 after purchasing an additional 1,771 shares during the period. Te Ahumairangi Investment Management Ltd lifted its holdings in shares of DaVita by 1.0% in the 3rd quarter. Te Ahumairangi Investment Management Ltd now owns 48,137 shares of the company’s stock worth $7,846,000 after purchasing an additional 500 shares during the last quarter. Toronto Dominion Bank boosted its position in DaVita by 6.9% during the 3rd quarter. Toronto Dominion Bank now owns 15,898 shares of the company’s stock valued at $2,606,000 after purchasing an additional 1,025 shares during the period. Finally, Neo Ivy Capital Management acquired a new stake in DaVita in the third quarter worth $726,000. Institutional investors and hedge funds own 90.12% of the company’s stock.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.